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Abstract Wingate test (WT) training programmes lasting
2–3 weeks lead to improved peak oxygen consumption. If a
single 30 s WT was capable of significantly increasing
stroke volume and cardiac output, the increase in peak
oxygen consumption could possibly be explained by
improved oxygen delivery. Thus, we investigated whether a
single WT increases stroke volume and cardiac output to
similar levels than those obtained at peak exercise during a
graded cycling exercise test (GXT) to exhaustion. Fifteen
healthy young men (peak oxygen consumption 45.0 ±
5.3 ml kg-1 min-1) performed one WT and one GXT on
separate days in randomised order. During the tests, we
estimated cardiac output using inert gas rebreathing (nitrous
oxide and sulphur hexafluoride) and subsequently calcu-
lated stroke volume. We found that cardiac output was
similar (18.2 ± 3.3 vs. 17.9 ± 2.6 l min-1; P = 0.744),
stroke volume was higher (127 ± 37 vs. 94 ± 15 ml;
P \ 0.001), and heart rate was lower (149 ± 26 vs.
190 ± 12 beats min-1; P \ 0.001) at the end (27 ± 2 s) of
a WT as compared to peak exercise during a GXT. Our
results suggest that a single WT produces a haemodynamic
response which is characterised by similar cardiac output,
higher stroke volume and lower heart rate as compared to
peak exercise during a GXT.
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Introduction
Sprint interval training (SIT) is a novel type of high-
intensity interval training consisting of 4–6 repeated all-out
30 s Wingate tests (WTs) separated by 4 min recovery. It
has been demonstrated that 2–3 weeks (3 training sessions
per week) of SIT increases peak oxygen consumption
(Burgomaster et al. 2008; Hazell et al. 2010). However, the
underlying adaptations in oxygen delivery and extraction
possibly mediating the increase in peak oxygen consump-
tion following SIT are not yet clear.
Peak oxygen consumption is bounded by the parametric
limits of the Fick equation (oxygen consumption = cardiac
output 9 arterio-venous oxygen difference) (Fick 1870). If
the increase in peak oxygen consumption after SIT was
mediated by an increase in peak cardiac output, it should be
expected that a single WT is capable of increasing cardiac
output to near-maximal values. In fact, high-intensity aer-
obic training (HIT) is more effective in mediating increases
in cardiac output and stroke volume than continuous
training at a power corresponding to lactate threshold
(Daussin et al. 2007; Helgerud et al. 2007). HIT is char-
acterised by 4–5 blocks of short (1–4 min) training inter-
vals at a power output corresponding to, e.g. 90–100%
peak power attained during a GXT, separated by 3–4 min
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at a power corresponding to 50–60% peak GXT power.
Daussin et al. (2007) concluded that the near-maximal
cardiac output attained during HIT mediates the observed
long-term adaptations in peak cardiac output and stroke
volume which, in turn, underlay the observed increase in
peak oxygen consumption after several weeks of HIT.
One study compared cardiac output and stroke volume
between a GXT and a WT by means of echocardiographic
measurements (Sagiv et al. 2000). It was concluded that
stroke volume is increased only with GXT, and that the
increase of cardiac output is significantly less for WT than
for GXT. This conclusion implies that a WT cannot pro-
vide a sufficiently high stimulus for triggering cardio-
circulatory adaptation, and consequently that the observed
increase in peak oxygen consumption after a WT training
programme (Burgomaster et al. 2008; Hazell et al. 2010)
cannot originate from an increase in peak stroke volume
and cardiac output. As echocardiographic measurements
are not feasible when the upper body is moving, the par-
ticipants’ backs had to be strapped to the wall in the study
of Sagiv et al. (2000). As an obvious consequence, the
participants could not generate as much power as during a
real WT with freely moving upper body. In this study, we
thus wanted to re-investigate the cardiac output response
during WT using an inert gas (nitrous oxide and sulphur
hexafluoride) rebreathing technique, which does not
restrict the participants’ position (and thus exercise
capacity).
Methods
Participants
Fifteen male participants of age 26.7 ± 5.6 years, height
1.81 ± 0.05 m, body mass 73.6 ± 7.0 kg and peak oxygen
consumption 45.0 ± 5.3 ml kg-1 min-1 volunteered to
participate in this study. All participants were healthy and
non-smoking. In order to avoid fatigue-related effects on
the test outcomes, we allowed no strenuous physical
activity for 48 h prior to the measurements. We informed
the participants about all procedures involved and about the
associated risks. Subsequently, participants completed a
routine health questionnaire and gave their written
informed consent. The experimental protocol was approved
by the ethics committee of the ETH Zurich and was per-
formed in accordance with the ethical standards laid down
in the Declaration of Helsinki for human experimentation.
Study design and experimental setup
Each participant performed one GXT on a cycle ergometer
(Ergoselect 200 K, Ergoline, Bitz, Germany) and one WT
(Ergomedic 894E Peak Bike, Monark, Vansbro, Sweden).
The two tests were separated by at least 48 h and were
performed in a randomised order. Each participant per-
formed the two tests at the same daytime. During GXT and
WT, cardiac output and stroke volume were estimated by
inert gas rebreathing (InnocorTM, Innovision, Odense,
Denmark). In addition, heart rate was continuously recor-
ded (S610i, Polar Electro, Kempele, Finland). Before the
tests, we informed the participants about the upcoming
procedures and they practiced the rebreathing technique
with ambient air (Fontana et al. 2009). No additional
familiarisation trials were performed prior to GXT and WT.
Prior to the start of the GXT, participants rested for
2 min on the cycle ergometer. Subsequently, they started
pedalling at 100 W using a self-selected pedalling rate
[70–90 revolutions per minute (rpm)], which was held
constant (±5 rpm) throughout the test. Power was
increased by 30 W for every 2 min until participants
stopped cycling or were unable to maintain pedalling rate
within the given limits for more than 5 s (mean GXT
duration 12.4 ± 2.5 min). We previously used the same
incremental protocol to show that test–retest reliability of
cardiac output and stroke volume during a GXT is high
(Fontana et al. 2009). Furthermore, we demonstrated that at
46 and 103 s after a power stage transition (54–69, 69–77
and 77–85% peak power) both cardiac output and stroke
volume are similar (Fontana et al. 2010), indicating that
less than 46 s are needed to reach a steady state for cardiac
output and stroke volume. For WT, participants started
unloaded pedalling as fast as possible. As soon as they
reached 130 rpm, the computer interfaced with the test
bike automatically loaded the ergometer with 7.5% of the
participant’s body weight (Burgomaster et al. 2005). Par-
ticipants were verbally encouraged to continue to pedal as
fast as possible.
Estimation of cardiac output
The rebreathing manoeuvres during GXT were performed
in accordance with our previously published protocol
(Fontana et al. 2009). We manually set the rebreathing
parameters to 3 l rebreathing volume and 10% bolus vol-
ume (volume of gas mixture, consisting of nitrous oxide,
sulphur hexafluoride and oxygen). During the rebreathing
manoeuvres, participants continued to spontaneously
breathe, as their breathing frequency was already high
enough while cycling. Breathing frequency was monitored
online by the examinator and participants were given ver-
bal feedback to maintain a constant breathing frequency.
All participants cycled until the software of the InnocorTM
indicated the end of the rebreathing. For WT, the exact
point in time (averaged over all participants) of the first
breath, which we used for fitting the regression line
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(calculation of cardiac output, represented by complete gas
mixing), was 27 ± 2 s (range 24–32 s) after the beginning
of the sprint bout (after loading). Given that the rebreathing
lasted *3 s, a WT lasted 27–35 s. Using the end tidal
nitrous oxide concentrations of at least two breaths, cardiac
output could be estimated in all study participants during
the final phase of WT, as well as at peak GXT. The
coefficient of variation (CV) over repeated preliminary
measurements of cardiac output during the final phase of a
WT for the investigator was 8%. This is in agreement with
values obtained for a GXT (95% confidence interval:
5.5–9%, Fontana et al. 2009).
Calculations
GXT
We calculated stroke volume at peak exercise by dividing
cardiac output by the heart rate measured during the
rebreathing (10 s average), corresponding to the highest
10 s average throughout the GXT (i.e. peak heart rate).
WT
WT stroke volume during the WT was obtained by divid-
ing cardiac output by heart rate. Here, we used a 5 instead
of a 10 s mean because of the shorter test duration. The
corresponding heart rate measurement started as soon as
the valve to the rebreathing bag opened during cardiac
output determination.
Statistical analysis
Statistical analyses were performed with SPSS software
(version 16.0, SPSS, Chicago, IL, USA). Normality of
ln-transformed data was ascertained by Q–Q plots. For
comparisons of cardiac output, stroke volume and heart
rate between GXT and the WT, we used Student’s paired
t test. Results are presented as mean ± standard deviation.
Statistical significance was set at P \ 0.05.
Results
Cardiac output at (or immediately before) the end of WT
and GXT was similar (Table 1). Furthermore, stroke
volume was higher (34 ± 31%), whereas heart rate
(-22 ± 12%) was lower at the end of WT compared to
GXT. Power (460 ± 54 vs. 286 ± 38 W; P \ 0.001) and
pedalling rate (89 ± 9 vs. 77 ± 5 rpm; P = 0.002) during
WT rebreathings were significantly higher than during
GXT rebreathings.
Discussion
In the present study, we found that cardiac output is similar
at the end of WT compared to the point in time of voli-
tional exhaustion during GXT in healthy young men. In
contrary to cardiac output, stroke volume was significantly
higher and heart rate was significantly lower for WT than
GXT. Our results contrast with the data of Sagiv et al.
(2000), who found that both cardiac output and stroke
volume were significantly higher for GXT than WT. We
ascribe the divergent results to the unnatural (i.e. fixed
upper body) WT condition used by Sagiv et al. (2000).
Having shown that a single WT is capable of increasing
cardiac output to maximal levels, we have provided novel,
scientific insight into the mechanistic bases possibly
underlying the increase in peak oxygen consumption which
is observed after 2–3 weeks of WT training programmes
(Burgomaster et al. 2008; Hazell et al. 2010). In fact, our
results suggest that the observed increase in peak oxygen
consumption after a WT training programme (Burgomaster
et al. 2008; Hazell et al. 2010) might originate from an
increase in peak cardiac output.
There are a few considerations pertinent to the estimation
of cardiac output that are warranted. First, the absorption of
nitrous oxide by the blood, and hence the calculation of
pulmonary blood flow (equal to cardiac output when there is
no pulmonary shunt flow), can be affected not only by
ventilation inhomogeneity but also by flow inhomogeneity.
If breathing frequency during the rebreathing manoeuvres is
not constant, the slope of the regression line through end-
tidal gas concentrations could yield a wrong estimate of
cardiac output. Only in 5 out of 30 rebreathing manoeuvres
participants could not maintain a constant breathing fre-
quency. For those rebreathings, we manually moved the
regression line to 2–3 breaths with a stable pulmonary blood
flow to correctly estimate cardiac output.
Second, pulmonary blood flow equals cardiac output
only if there is no significant pulmonary shunt flow.
Eldridge et al. (2004) showed that arterio-venous intra-
pulmonary shunts develop at about 59% peak oxygen
consumption and persist at all subsequent power stages.
Table 1 Cardiac output, stroke volume and heart rate in 15 young
healthy men at the end of a Wingate test (WT), as well as at the point
in time of volitional exhaustion during a graded cycling exercise test
(GXT)
Wingate
test (WT)
Graded cycling
exercise test (GXT)
P
Cardiac output (l min-1) 18.2 ± 3.3 17.9 ± 2.6 0.744
Stroke volume (ml) 127 ± 37 94 ± 15 \0.001
Heart rate (beats min-1) 149 ± 26 190 ± 12 \0.001
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Thus, in both exercise modalities, arterio-venous intrapul-
monary shunts may have developed. Assuming for each
participant a blood haemoglobin concentration of
15 g dl-1 and considering the respective arterial oxygen
saturations (data not shown), we found that during a GXT,
the estimated arterio-venous intrapulmonary shunt fraction
tended to be higher (6.0 ± 2.7%) than during a WT
(1.9 ± 2.7%). However, even when considering these
possible differences in estimated arterio-venous intrapul-
monary shunt flow, our findings presented in Table 1 do
not significantly change.
Finally, we want to address the issue that maximal
stroke volume might have been underestimated during the
GXT. It appears that during a GXT with constant power
increments, stroke volume reaches maximal values already
at 64% peak power and remains at this level until
exhaustion (Calbet et al. 2007; Fontana et al. 2010). In
contrast, for GXT protocols with varying power increments
it has been shown that stroke volume is maximal at 80%
and subsequently decreases to reach a significantly lower
value at exhaustion (Mortensen et al. 2005). Besides dif-
ferences in exercise protocols, levels of exertion, exercise
mode, sex, age and training status also might lead to dif-
ferent responses in stroke volume. Given the fact that we
used a GXT with constant power increments and that the
participants’ sex, age as well as training status was similar
in the study by Calbet et al. (2007), we believe that we
report (near-)maximal values for stroke volume in the
present study.
We conclude that a single, unrestricted WT produces a
haemodynamic response which is characterised by similar
cardiac output, higher stroke volume and lower heart rate
compared to peak exercise during a GXT in young men.
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